Patents
More topics under "C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes" (300,877)
C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
C12Q 3 - Condition-responsive control processes (646)
Patents for C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes (2,829)
12/2003
12/11/2003WO2003102219A2 Improved pseudotyped retroviruses
12/11/2003WO2003102211A2 Method of detecting dna variation in sequence data
12/11/2003WO2003102209A2 Alternatively spliced isoforms of human hmg co-a reductase
12/11/2003WO2003054212A3 A method and compositions for conferring viral immunity and reversing viral pathogenesis via strategic infection with a theravirus thereby providing genomic integration of genetically engineered, replication incompetent, integrating viral dna
12/11/2003WO2003052116A3 Methods for detection of a target nucleic acid using multi-subunit probes
12/11/2003WO2003040400A3 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
12/11/2003US20030229904 Comprises polypeptide for diagnosis, treatment and prevention of tumors
12/11/2003US20030229020 Vaccine; induce immunology response; administering monoclonal antibodies
12/11/2003US20030228591 Methods for searching polynucleotide probe targets in databases
12/04/2003WO2003100082A2 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003WO2003100076A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria
12/04/2003US20030224437 Discriminately identifying nucleic acid sequences of coliform bacteria; high throughput assay
12/04/2003CA2486193A1 Methods of determining precise herg interactions and altering compounds based on said interactions
12/04/2003CA2484010A1 Pna probes, probe sets, methods and kits pertaining to the determination of listeria
12/03/2003EP1366360A2 Methods for large scale protein matching
12/02/2003CA2046904C Cd4 specific recombinant antibody
11/2003
11/27/2003WO2003097855A2 Small molecule inhibitors of her2 expression
11/27/2003WO2003097852A2 Assay for identifying inhibitors of fc gamma riii signaling
11/27/2003WO2003078589A3 Method of identifying genes controlling diferentiation
11/27/2003WO2003044214A3 Methods and compositions in checkpoint signaling
11/27/2003WO2003040401A3 General screening method for ligand-protein interactions
11/27/2003US20030219792 Using recombinase-polymerase amplification to propagate target DNA without the use of thermocycling or thermophilic enzymes
11/27/2003US20030219779 Transposon mediated multiplex sequencing
11/27/2003CA2485589A1 Small molecule inhibitors of her2 expression
11/26/2003EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
11/26/2003EP1364052A2 High throughput or capillary-based screening for a bioactivity or biomolecule
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2002083920A3 Nucleic acid sequences useful in the detection and treatment of various cancers
11/11/2003US6645492 For diagnosis and therapy of susceptibility to atopic allergy, asthma
11/06/2003WO2003070964A3 Methods for searching polynucleotide probe targets in databases
11/06/2003WO2002059348A3 Methods for determining the genetic affinity of microorganisms and viruses
11/06/2003WO2002057489A3 Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
11/06/2003US20030208045 Binds to Osteoclastogenesis Inhibitory Factor (OCIF) binding molecule (OBM)
10/2003
10/30/2003WO2003006678A3 System and method for storing mass spectrometry data
10/30/2003US20030203374 Assaying cells in a biological sample to distinguish between living and dead cells
10/29/2003CN1125877C Hepatitis G. Virus and molecular cloning thereof
10/23/2003US20030198959 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/16/2003WO2003085585A1 A method for gene mapping from genotype and phenotype data
10/16/2003WO2003085124A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/16/2003WO2002079488A3 Oligonucleotide microchips to detect protein-nucleic acid interactions
10/16/2003WO2002077262A3 Method and apparatus for the automated generation of nucleic acid ligands
10/16/2003WO2002072868A3 Methods and tools for nucleic acid sequence analysis selection and generation
10/16/2003US20030194725 Creating a database of related protein/nucleic acid sequences with annotations of the potential disease associations of the sequences; testing the potential disease associations by means of a biological assay and validating the disease association
10/16/2003CA2480450A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/15/2003EP1352063A2 Receptor nucleic acids and polypeptides
10/09/2003WO2003082202A2 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/09/2003WO2002083929A3 System and method for quantitating transcription factors
10/09/2003WO2001071027A3 mRNA AMPLIFICATION
10/09/2003CA2479379A1 Methods and compositions for analysis of urine samples in the diagnosis and treatment of kidney diseases
10/02/2003US20030186316 Method for identifying optimal binding ligands to a receptor
10/01/2003EP0868529B1 Method for detection of ki-ras mutations and kit to perform it
09/2003
09/30/2003US6627226 Dry solid medium for storage and analysis of genetic material
09/25/2003WO2003078652A2 Modification of selectivity for sensing for nanostructure device arrays
09/25/2003WO2003078589A2 Method of identifying genes controlling diferentiation
09/25/2003WO2002061128A3 Method of determining a chemotherapeutic regimen based on ercc1 expression
09/25/2003WO2002031203A3 High throughput or capillary-based screening for a bioactivity or biomolecule
09/25/2003CA2478986A1 Method of identifying genes controlling differentiation
09/18/2003WO2002031181A3 Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
09/18/2003US20030176647 Antibodies to OCIF-binding molecules
09/18/2003US20030175714 Method for generating amplified RNA
09/18/2003US20030175254 Separating population based on density and size of cells via elution then cetrifugation; for secretion of neuroendocrine hormones
09/18/2003US20030175161 For electronic detection of chemical and biological materials
09/17/2003CN1443192A Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
09/12/2003WO2003074724A2 Polynomial amplification of nucleic acids
09/12/2003WO2002090569A3 Family-based association tests for quantitative traits using pooled dna
09/12/2003WO2002057414A9 Leukocyte expression profiling
09/04/2003WO2003072826A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/04/2003WO2003072805A2 Recombinase polymerase amplification
09/04/2003WO2003072798A2 Method for generating amplified rna
09/04/2003WO2002101069A3 Ns4 nucleic acids and polypeptides and methods of use for the treatment of body weight disorders
09/04/2003US20030165934 Methods and compositions in checkpoint signaling
09/04/2003US20030165840 Comprises replication of oligonucleotides for detection, diagnosis and treatment of cancer using 5-Fluorouracil-based chemotherapeutic regimen
09/04/2003CA2476661A1 Method for generating amplified rna
09/04/2003CA2476481A1 Recombinase polymerase amplification
09/04/2003CA2457907A1 Stain-directed molecular analysis for cancer prognosis and diagnosis
09/03/2003EP1339869A2 Obesity associated biallelic marker maps
09/03/2003CN1439646A Method for segregating nucleic acid
08/2003
08/28/2003WO2003070974A2 Mismatch repair detection
08/28/2003WO2003070965A2 The eaat2 promoter and uses thereof
08/28/2003WO2003070964A2 Methods for searching polynucleotide probe targets in databases
08/28/2003US20030162213 Terminal-phosphate-labeled nucleotides and methods of use
08/28/2003CA2475188A1 Mismatch repair detection
08/27/2003EP1337546A2 Method for detecting hematopoietic stem cells
08/27/2003CN1119658C Method for quantitating cholesterol present in low density lipoproteins
08/21/2003WO2003060142A9 Compositions and methods for controlled release
08/21/2003WO2003004686A3 Fluorescence-based assay for the detection of specific nucleic acids using photon counting
08/21/2003WO2002008446A9 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries
08/19/2003US6607896 Diagnostic test
08/14/2003WO2003066882A2 Method and apparatus for validating dna sequences without sequencing
08/14/2003WO2003066878A2 Nucleic acid analysis using layered expression scanning
08/14/2003US20030152947 Methods for detecting and treating the early onset of aging-related conditions
08/13/2003EP1334113A2 Leukocyte expression profiling
08/07/2003US20030148345 Methods for evaluating drug-resistance gene expression in the cancer patient
08/07/2003US20030148343 Methods for detecting and quantifying binding and inhibition of binding of species to nucleic acids
08/07/2003US20030148310 Incubating; signal generated after dissociation; increased intensity; does not require cleavage
08/06/2003CN1435028A System and method for communicating data over multiple networks
08/06/2003CN1434832A DNA for encoding the RGI polypeptide
08/05/2003US6602670 Treating tumors; obtain tissue sample, isolate nucleotide sequences, amplify nucleotide sequences, monitor nucleotide sequence concentration of marker gene, compare to control
07/2003
07/31/2003WO2003062450A2 Probe correction for gene expression level detection
07/31/2003WO2002024909A3 Receptor nucleic acids and polypeptides
1 ... 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29